Article

From the clinic to the bench and back again in one dog year: identifying new treatments for sarcoma using a cross-species personalized medicine pipeline

2019-01-10

Abstract excerpt

Cancer drug discovery is an inefficient process, with more than 90% of newly-discovered therapies failing to gain regulatory approval. Patient-derived models of cancer offer a promising new approach to identifying personalized treatments; however, for rare cancers, such as sarcomas, access to patient samples can be extremely limited, which precludes development of patient-derived models. To address the limited acc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fda55c70-f962-5b7d-9161-509e8ca954cb
DOI: 10.1101/517086

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

From the clinic to the bench and back again in one dog year: identifying new treatments for sarcoma using a cross-species personalized medicine pipelineDOI 10.1101/517086Read

From the Clinic to the Bench and Back Again in One Dog Year: How a Cross-Species Pipeline to Identify New Treatments for Sarcoma Illuminates the Path Forward in Precision MedicineSemantic proximity Read

Bringing the Genomic Revolution to Comparative Oncology: Human and Dog CancersSemantic proximity Read

Large Scale Comparative Deconvolution Analysis of the Canine and Human Osteosarcoma Tumor Microenvironment Uncovers Conserved Clinically Relevant SubtypesSemantic proximity Read

Leading the pack: Best practices in comparative canine cancer genomics to inform human oncologySemantic proximity Read

Analyses of canine cancer mutations and treatment outcomes using real-world clinico-genomics data of 2119 dogsSemantic proximity Read

Leveraging Dog Models to Uncover Human Cancer InsightsSemantic proximity Read

Integrated analysis of canine soft tissue sarcomas identifies recurrent mutations in TP53, KMT genes and PDGFB fusions.Semantic proximity Read

Real-world evidence couples genomic biomarkers with therapeutic outcomes for canine hemangiosarcomaSemantic proximity Read

Large-Scale Comparative Analysis of Canine and Human Osteosarcomas Uncovers Conserved Clinically Relevant Tumor Microenvironment SubtypesSemantic proximity Read

A living biobank of canine mammary tumor organoids as a comparative model for human breast cancerSemantic proximity Read

Multi-omic Longitudinal Analysis of Canine Osteosarcoma Identifies Inter-Patient Heterogeneity and Immune Enrichment in Metastatic LesionsSemantic proximity Read

The tree that hides the forest: identification of common predisposing loci in several hematopoietic cancers and several dog breedsSemantic proximity Read